Archives of Neurology · 1963 · 67 citations · 8 references
MedicineNeurosurgerySurgeryNeurologic PharmacotherapyNeuropharmacologyTrauma NeurosurgeryCorticosteroid PharmacologyCorticosteroid TherapyIntrathecal Drug DeliveryConcentrationIntra-articular Corticosteroid UseIntrathecal AdministrationLong-term Corticosteroid ManagementMethylprednisolone UseSubarachnoid Space
<h3>Introduction</h3> Methylprednisolone acetate<sup>*</sup>has been administered intrathecally in more than 1,000 patients for the treatment of neurologic disorders<sup>1-3</sup>during the last three years. The treatment has proved safe, and the results are encouraging. It has become a standard method of treatment for arachnoiditis resulting from trauma, Pantopaque, or laminectomy. With this new method of administration we thought it expedient to ascertain: first, how long methylprednisolone acetate remains in the cerebrospinal fluid after intrathecal administration; secondly, whether methylprednisolone acetate injected at the lumbar level is dispersed evenly throughout the subarachnoid space, or remains in a higher concentration at the site of injection, by analyzing fluids obtained simultaneously at lumbar and cisternal punctures; thirdly, the duration of action of the steroid as judged by the effect on endogenous secretion of corticosteroids; fourthly, the effect on spinal fluid pressure, protein and cell content of various amounts of methylprednisolone acetate. <h3>Methods, Procedures, and</h3>
8
THE FATE OF HYDROCORTISONE-4-C14 IN MAN 1
LEON HELLMAN, H. Leon Bradlow, Jerome Adesman et al. · Journal of Clinical Investigation · 1954 · 93 citations · Full text